“Codivir Performs Well Against Mutations” | IssueWire
Code Pharma CEO and Founder, Zyon Ayni, said in a press release on IssueWire: “scientific data on Codivir’s mechanism of action has proven strongly that
December 9, 2021
Tag: IssueWire
Code Pharma CEO and Founder, Zyon Ayni, said in a press release on IssueWire: “scientific data on Codivir’s mechanism of action has proven strongly that